The Enterprise Value as of December 2024 (TTM) for Structure Therapeutics Inc. (GPCR) is 1.47B

According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.47B. This represents a change of -18.18% compared to the average of 1.79B of the last 4 quarters.

Structure Therapeutics Inc. (GPCR) Historical Enterprise Value (quarterly & annually)

How has GPCR Enterprise Value performed in the past?

The mean historical Enterprise Value of Structure Therapeutics Inc. over the last ten years is 1.03B. The current 1.47B Enterprise Value has changed 14.10% with respect to the historical average. Over the past ten years (40 quarters), GPCR's Enterprise Value was at its highest in in the September 2024 quarter at 2.00B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

Structure Therapeutics Inc. (GPCR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Structure Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Structure Therapeutics Inc. (GPCR) Average Enterprise Value

How has GPCR Enterprise Value performed in the past?

The current Enterprise Value of Structure Therapeutics Inc. (GPCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Structure Therapeutics Inc. (GPCR) Enterprise Value vs. Peers

How is GPCR’s Enterprise Value compared to its peers?

Structure Therapeutics Inc.’s Enterprise Value is greater than Day One Biopharmaceuticals, Inc. (859.59M), greater than X4 Pharmaceuticals, Inc. (79.21M), greater than Inozyme Pharma, Inc. (215.58M), greater than Acumen Pharmaceuticals, Inc. (103.15M), greater than Mereo BioPharma Group plc (445.16M), greater than Terns Pharmaceuticals, Inc. (234.86M), greater than Amylyx Pharmaceuticals, Inc. (209.72M), greater than Eledon Pharmaceuticals, Inc. (244.06M), greater than HOOKIPA Pharma Inc. (-37325309.00), greater than Biomea Fusion, Inc. (67.66M), less than Disc Medicine, Inc. (1.71B), less than DICE Therapeutics, Inc. (1.82B), less than Morphic Holding, Inc. (2.81B),

Build a custom stock screener for Structure Therapeutics Inc. (GPCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Structure Therapeutics Inc. (GPCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.